{
    "abstract": "The secreted growth factor Activin-A of the transforming growth factor \u03b2 family and its receptors can promote or inhibit several cancer hallmarks including tumor cell proliferation and differentiation, vascularization, lymphangiogenesis and inflammation. However, a role in immune evasion and its relationship with tumor-induced muscle wasting and tumor vascularization, and the relative contributions of autocrine versus paracrine Activin signaling remain to be evaluated. To address this, we compared the effects of truncated soluble Activin receptor IIB as a ligand trap, or constitutively active mutant type IB receptor versus secreted Activin-A or the related ligand Nodal in mouse and human melanoma cell lines and tumor grafts. We found that although cell-autonomous receptor activation arrested tumor cell proliferation, Activin-A secretion stimulated melanoma cell dedifferentiation and tumor vascularization by functional blood vessels, and it increased primary and metastatic tumor burden and muscle wasting. Importantly, in mice with impaired adaptive immunity, the tumor-promoting effect of Activin-A was lost despite sustained vascularization and cachexia, suggesting that Activin-A promotes melanoma progression by inhibiting antitumor immunity. Paracrine Activin-A signaling emerges as a potential target for personalized therapies, both to reduce cachexia and to enhance the efficacy of immunotherapies.",
    "bib_entries": {
        "bib1": {
            "authors": [
                {
                    "first": "Tuomo",
                    "initial": "T.",
                    "last": "Alanko"
                },
                {
                    "first": "Olli",
                    "initial": "O.",
                    "last": "Saksela"
                }
            ],
            "doi": "10.1046/j.1523-1747.2000.00045.x",
            "firstpage": "286",
            "issn": "0022202X",
            "lastpage": "291",
            "pmid": "10951248",
            "pub_year": 2000,
            "title": "Transforming growth factor \u03b21 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gel",
            "volume": "115"
        },
        "bib10": {
            "authors": [
                {
                    "first": "I. J.",
                    "initial": "I.J.",
                    "last": "Fidler"
                }
            ],
            "doi": "10.1038/newbio242148a0",
            "firstpage": "148",
            "issn": "00900028",
            "lastpage": "149",
            "pmid": "4512654",
            "pub_year": 1973,
            "title": "Selection of successive tumour lines for metastasis",
            "volume": "242"
        },
        "bib11": {
            "authors": [
                {
                    "first": "Fran\u00e7ois",
                    "initial": "F.",
                    "last": "Ghiringhelli"
                },
                {
                    "first": "Pierre E.",
                    "initial": "P.E.",
                    "last": "Puig"
                },
                {
                    "first": "Stephan",
                    "initial": "S.",
                    "last": "Roux"
                },
                {
                    "first": "Arnaud",
                    "initial": "A.",
                    "last": "Parcellier"
                },
                {
                    "first": "Elise",
                    "initial": "E.",
                    "last": "Schmitt"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Solary"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Kroemer"
                },
                {
                    "first": "Fran\u00e7ois",
                    "initial": "F.",
                    "last": "Martin"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Chauffert"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Zitvogel"
                }
            ],
            "doi": "10.1084/jem.20050463",
            "firstpage": "919",
            "issn": "00221007",
            "lastpage": "929",
            "pmid": "16186184",
            "pub_year": 2005,
            "title": "Tumor cells convert immature myeloid dendritic cells into TGF-\u03b2-secreting cells inducing CD4 +CD25 + regulatory T cell proliferation",
            "volume": "202"
        },
        "bib12": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Gorelink"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Flavell"
                }
            ],
            "doi": "10.1038/nm1001-1118",
            "firstpage": "1118",
            "issn": "10788956",
            "lastpage": "1122",
            "pmid": "11590434",
            "pub_year": 2001,
            "title": "Immune-mediated eradication of tumors through the blockade of transforming growth factor-\u03b2 signaling in T cells",
            "volume": "7"
        },
        "bib13": {
            "authors": [
                {
                    "first": "Kira",
                    "initial": "K.",
                    "last": "Gritsman"
                },
                {
                    "first": "Jiaojiao",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Cheng"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Heckscher"
                },
                {
                    "first": "William S.",
                    "initial": "W.S.",
                    "last": "Talbot"
                },
                {
                    "first": "Alexander F.",
                    "initial": "A.F.",
                    "last": "Schier"
                }
            ],
            "doi": "10.1016/S0092-8674(00)80720-5",
            "firstpage": "121",
            "issn": "00928674",
            "lastpage": "132",
            "pmid": "10199408",
            "pub_year": 1999,
            "title": "The EGF-CFC protein one-eyed pinhead is essential for nodal signaling",
            "volume": "97"
        },
        "bib14": {
            "authors": [
                {
                    "first": "Mark P.",
                    "initial": "M.P.",
                    "last": "Hedger"
                },
                {
                    "first": "Wendy R.",
                    "initial": "W.R.",
                    "last": "Winnall"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Phillips"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "de Kretser"
                }
            ],
            "doi": "10.1016/B978-0-12-385961-7.00013-5",
            "firstpage": "255",
            "issn": "00836729",
            "lastpage": "297",
            "pmid": "21353885",
            "pub_year": 2011,
            "title": "The Regulation and Functions of Activin and Follistatin in Inflammation and Immunity",
            "volume": "85"
        },
        "bib15": {
            "authors": [
                {
                    "first": "Magdalena",
                    "initial": "M.",
                    "last": "Heinz"
                },
                {
                    "first": "Heide Leb",
                    "initial": "H.L.",
                    "last": "Niederleithner"
                },
                {
                    "first": "Emmi",
                    "initial": "E.",
                    "last": "Puujalka"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Soler-Cardona"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Grusch"
                },
                {
                    "first": "Hubert",
                    "initial": "H.",
                    "last": "Pehamberger"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Loewe"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Petzelbauer"
                }
            ],
            "doi": "10.1038/jid.2014.328",
            "firstpage": "212",
            "issn": "0022202X",
            "lastpage": "221",
            "pmid": "25084052",
            "pub_year": 2015,
            "title": "Activin A is Anti-Lymphangiogenic in a Melanoma Mouse Model",
            "volume": "135"
        },
        "bib16": {
            "authors": [
                {
                    "first": "Mir Alireza",
                    "initial": "M.A.",
                    "last": "Hoda"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Rozsas"
                },
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Lang"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Klikovits"
                },
                {
                    "first": "Zoltan",
                    "initial": "Z.",
                    "last": "Lohinai"
                },
                {
                    "first": "Szilvia",
                    "initial": "S.",
                    "last": "Torok"
                },
                {
                    "first": "Judit",
                    "initial": "J.",
                    "last": "Berta"
                },
                {
                    "first": "Matyas",
                    "initial": "M.",
                    "last": "Bendek"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Berger"
                },
                {
                    "first": "Balazs",
                    "initial": "B.",
                    "last": "Hegedus"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Klepetko"
                },
                {
                    "first": "Ferenc",
                    "initial": "F.",
                    "last": "Renyi-Vamos"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Grusch"
                },
                {
                    "first": "Balazs",
                    "initial": "B.",
                    "last": "Dome"
                },
                {
                    "first": "Viktoria",
                    "initial": "V.",
                    "last": "Laszlo"
                }
            ],
            "doi": "10.18632/oncotarget.7796",
            "firstpage": "13388",
            "issn": "19492553",
            "lastpage": "13399",
            "pmid": "26950277",
            "pub_year": 2016,
            "title": "High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma",
            "volume": "7"
        },
        "bib17": {
            "authors": [
                {
                    "first": "Keith S.",
                    "initial": "K.S.",
                    "last": "Hoek"
                },
                {
                    "first": "Ossia M.",
                    "initial": "O.M.",
                    "last": "Eichhoff"
                },
                {
                    "first": "Natalie C.",
                    "initial": "N.C.",
                    "last": "Schlegel"
                },
                {
                    "first": "Udo",
                    "initial": "U.",
                    "last": "D\u00f6bbeling"
                },
                {
                    "first": "Nikita",
                    "initial": "N.",
                    "last": "Kobert"
                },
                {
                    "first": "Leo",
                    "initial": "L.",
                    "last": "Schaerer"
                },
                {
                    "first": "Silvio",
                    "initial": "S.",
                    "last": "Hemmi"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Dummer"
                }
            ],
            "doi": "10.1158/0008-5472.CAN-07-2491",
            "firstpage": "650",
            "issn": "00085472",
            "lastpage": "656",
            "pmid": "18245463",
            "pub_year": 2008,
            "title": "In vivo switching of human melanoma cells between proliferative and invasive states",
            "volume": "68"
        },
        "bib18": {
            "authors": [
                {
                    "first": "Keith S.",
                    "initial": "K.S.",
                    "last": "Hoek"
                },
                {
                    "first": "Natalie C.",
                    "initial": "N.C.",
                    "last": "Schlegel"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Brafford"
                },
                {
                    "first": "Antje",
                    "initial": "A.",
                    "last": "Sucker"
                },
                {
                    "first": "Selma",
                    "initial": "S.",
                    "last": "Ugurel"
                },
                {
                    "first": "Rajiv",
                    "initial": "R.",
                    "last": "Kumar"
                },
                {
                    "first": "Barbara L.",
                    "initial": "B.L.",
                    "last": "Weber"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "Nathanson"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Phillips"
                },
                {
                    "first": "Meenhard",
                    "initial": "M.",
                    "last": "Herlyn"
                },
                {
                    "first": "Dirk",
                    "initial": "D.",
                    "last": "Schadendorf"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Dummer"
                }
            ],
            "doi": "10.1111/j.1600-0749.2006.00322.x",
            "firstpage": "290",
            "issn": "08935785",
            "lastpage": "302",
            "pmid": "16827748",
            "pub_year": 2006,
            "title": "Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature",
            "volume": "19"
        },
        "bib19": {
            "authors": [
                {
                    "first": "Delphine",
                    "initial": "D.",
                    "last": "Javelaud"
                },
                {
                    "first": "V\u00e9ronique",
                    "initial": "V.",
                    "last": "Delmas"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "M\u00f6ller"
                },
                {
                    "first": "Peggy",
                    "initial": "P.",
                    "last": "Sextius"
                },
                {
                    "first": "Jocelyne",
                    "initial": "J.",
                    "last": "Andr\u00e9"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Menashi"
                },
                {
                    "first": "Lionel",
                    "initial": "L.",
                    "last": "Larue"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Mauviel"
                }
            ],
            "doi": "10.1038/sj.onc.1208900",
            "firstpage": "7624",
            "issn": "09509232",
            "lastpage": "7629",
            "pmid": "16007121",
            "pub_year": 2005,
            "title": "Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo",
            "volume": "24"
        },
        "bib2": {
            "authors": [
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Antsiferova"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Huber"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Meyer"
                },
                {
                    "first": "Aleksandra",
                    "initial": "A.",
                    "last": "Piwko-Czuchra"
                },
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Ramadan"
                },
                {
                    "first": "Amanda S.",
                    "initial": "A.S.",
                    "last": "MacLeod"
                },
                {
                    "first": "Wendy L.",
                    "initial": "W.L.",
                    "last": "Havran"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Dummer"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Hohl"
                },
                {
                    "first": "Sabine",
                    "initial": "S.",
                    "last": "Werner"
                }
            ],
            "doi": "10.1038/ncomms1585",
            "issn": "20411723",
            "pmid": "22146395",
            "pub_year": 2011,
            "title": "Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response",
            "volume": "2"
        },
        "bib20": {
            "authors": [
                {
                    "first": "Delphine",
                    "initial": "D.",
                    "last": "Javelaud"
                },
                {
                    "first": "Khalid S.",
                    "initial": "K.S.",
                    "last": "Mohammad"
                },
                {
                    "first": "Christopher R.",
                    "initial": "C.R.",
                    "last": "McKenna"
                },
                {
                    "first": "Pierrick",
                    "initial": "P.",
                    "last": "Fournier"
                },
                {
                    "first": "Flavie",
                    "initial": "F.",
                    "last": "Luciani"
                },
                {
                    "first": "Maryla",
                    "initial": "M.",
                    "last": "Niewolna"
                },
                {
                    "first": "Jocelyne",
                    "initial": "J.",
                    "last": "Andr\u00e9"
                },
                {
                    "first": "V\u00e9ronique",
                    "initial": "V.",
                    "last": "Delmas"
                },
                {
                    "first": "Lionel",
                    "initial": "L.",
                    "last": "Larue"
                },
                {
                    "first": "Theresa A.",
                    "initial": "T.A.",
                    "last": "Guise"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Mauviel"
                }
            ],
            "doi": "10.1158/0008-5472.CAN-06-3950",
            "firstpage": "2317",
            "issn": "00085472",
            "lastpage": "2324",
            "pmid": "17332363",
            "pub_year": 2007,
            "title": "Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis",
            "volume": "67"
        },
        "bib21": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Kaneda"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Arao"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Matsumoto"
                },
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "De Velasco"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Tamura"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Aomatsu"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Kudo"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sakai"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Nagai"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Fujita"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Tanaka"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Yanagihara"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Yamada"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Okamoto"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Nakagawa"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Nishio"
                }
            ],
            "doi": "10.1038/bjc.2011.348",
            "firstpage": "1210",
            "issn": "00070920",
            "lastpage": "1217",
            "pmid": "21897392",
            "pub_year": 2011,
            "title": "Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer",
            "volume": "105"
        },
        "bib22": {
            "authors": [
                {
                    "first": "Jelena",
                    "initial": "J.",
                    "last": "Krneta"
                },
                {
                    "first": "Jens",
                    "initial": "J.",
                    "last": "Kroll"
                },
                {
                    "first": "Frauke",
                    "initial": "F.",
                    "last": "Alves"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Prahst"
                },
                {
                    "first": "Farahnaz",
                    "initial": "F.",
                    "last": "Sananbenesi"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Dullin"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Kimmina"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Phillips"
                },
                {
                    "first": "Hellmut G.",
                    "initial": "H.G.",
                    "last": "Augustin"
                }
            ],
            "doi": "10.1158/0008-5472.CAN-05-3821",
            "firstpage": "5686",
            "issn": "00085472",
            "lastpage": "5695",
            "pmid": "16740706",
            "pub_year": 2006,
            "title": "Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors",
            "volume": "66"
        },
        "bib23": {
            "authors": [
                {
                    "first": "Peter Kar Han",
                    "initial": "P.K.H.",
                    "last": "Lau"
                },
                {
                    "first": "Paolo A.",
                    "initial": "P.A.",
                    "last": "Ascierto"
                },
                {
                    "first": "Grant",
                    "initial": "G.",
                    "last": "McArthur"
                }
            ],
            "doi": "10.1016/j.coi.2015.12.006",
            "firstpage": "30",
            "issn": "09527915",
            "lastpage": "38",
            "pmid": "26765776",
            "pub_year": 2016,
            "title": "Melanoma: The intersection of molecular targeted therapy and immune checkpoint inhibition",
            "volume": "39"
        },
        "bib24": {
            "authors": [
                {
                    "first": "Claire E.",
                    "initial": "C.E.",
                    "last": "Lewis"
                },
                {
                    "first": "Allison S.",
                    "initial": "A.S.",
                    "last": "Harney"
                },
                {
                    "first": "Jeffrey W.",
                    "initial": "J.W.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1016/j.ccell.2016.05.017",
            "firstpage": "18",
            "issn": "15356108",
            "lastpage": "25",
            "pmid": "27411586",
            "pub_year": 2016,
            "title": "The Multifaceted Role of Perivascular Macrophages in Tumors",
            "volume": "30"
        },
        "bib25": {
            "authors": [
                {
                    "first": "Qinglei",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Kumar"
                },
                {
                    "first": "Kathryn",
                    "initial": "K.",
                    "last": "Underwood"
                },
                {
                    "first": "Anne E.",
                    "initial": "A.E.",
                    "last": "O'Connor"
                },
                {
                    "first": "Kate L.",
                    "initial": "K.L.",
                    "last": "Loveland"
                },
                {
                    "first": "Jasbir S.",
                    "initial": "J.S.",
                    "last": "Seehra"
                },
                {
                    "first": "Martin M.",
                    "initial": "M.M.",
                    "last": "Matzuk"
                }
            ],
            "doi": "10.1093/molehr/gam055",
            "firstpage": "675",
            "issn": "13609947",
            "lastpage": "683",
            "pmid": "17704537",
            "pub_year": 2007,
            "title": "Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein",
            "volume": "13"
        },
        "bib26": {
            "authors": [
                {
                    "first": "Enza",
                    "initial": "E.",
                    "last": "Lonardo"
                },
                {
                    "first": "Patrick C.",
                    "initial": "P.C.",
                    "last": "Hermann"
                },
                {
                    "first": "Maria Theresa",
                    "initial": "M.T.",
                    "last": "Mueller"
                },
                {
                    "first": "Stephan",
                    "initial": "S.",
                    "last": "Huber"
                },
                {
                    "first": "Anamaria",
                    "initial": "A.",
                    "last": "Balic"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Miranda-Lorenzo"
                },
                {
                    "first": "Sladjana",
                    "initial": "S.",
                    "last": "Zagorac"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Alcala"
                },
                {
                    "first": "Iker",
                    "initial": "I.",
                    "last": "Rodriguez-Arabaolaza"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Ramirez"
                },
                {
                    "first": "Raul",
                    "initial": "R.",
                    "last": "Torres-Ru\u00edz"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Garcia"
                },
                {
                    "first": "Manuel",
                    "initial": "M.",
                    "last": "Hidalgo"
                },
                {
                    "first": "David \u00c1lvaro",
                    "initial": "D.A.",
                    "last": "Cebri\u00e1n"
                },
                {
                    "first": "Rainer",
                    "initial": "R.",
                    "last": "Heuchel"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "L\u00f6hr"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Berger"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Bartenstein"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Aicher"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Heeschen"
                }
            ],
            "doi": "10.1016/j.stem.2011.10.001",
            "firstpage": "433",
            "issn": "19345909",
            "lastpage": "446",
            "pmid": "22056140",
            "pub_year": 2011,
            "title": "Nodal/activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy",
            "volume": "9"
        },
        "bib27": {
            "authors": [
                {
                    "first": "Holli A.",
                    "initial": "H.A.",
                    "last": "Loomans"
                },
                {
                    "first": "Claudia D.",
                    "initial": "C.D.",
                    "last": "Andl"
                },
                {
                    "first": "Claudia D.",
                    "initial": "C.D.",
                    "last": "Andl"
                },
                {
                    "first": "Claudia D.",
                    "initial": "C.D.",
                    "last": "Andl"
                },
                {
                    "first": "Claudia D.",
                    "initial": "C.D.",
                    "last": "Andl"
                },
                {
                    "first": "Claudia D.",
                    "initial": "C.D.",
                    "last": "Andl"
                }
            ],
            "doi": "10.3390/cancers7010070",
            "firstpage": "70",
            "issn": "20726694",
            "lastpage": "91",
            "pub_year": 2014,
            "title": "Intertwining of activin a and TGF\u03b2 signaling: Dual roles in cancer progression and cancer cell invasion",
            "volume": "7"
        },
        "bib28": {
            "authors": [
                {
                    "first": "Carole Yolande",
                    "initial": "C.Y.",
                    "last": "Perrot"
                },
                {
                    "first": "Delphine",
                    "initial": "D.",
                    "last": "Javelaud"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Mauviel"
                }
            ],
            "doi": "10.5021/ad.2013.25.2.135",
            "firstpage": "135",
            "issn": "10139087",
            "lastpage": "144",
            "pub_year": 2013,
            "title": "Insights into the transforming growth factor-\u03b2 signaling pathway in cutaneous melanoma",
            "volume": "25"
        },
        "bib29": {
            "authors": [
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Pinner"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Jordan"
                },
                {
                    "first": "Kirsty",
                    "initial": "K.",
                    "last": "Sharrock"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Bazley"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Collinson"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Marais"
                },
                {
                    "first": "Elise",
                    "initial": "E.",
                    "last": "Bonvin"
                },
                {
                    "first": "Colin",
                    "initial": "C.",
                    "last": "Goding"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Sahai"
                }
            ],
            "doi": "10.1158/0008-5472.CAN-09-0781",
            "firstpage": "7969",
            "issn": "00085472",
            "lastpage": "7977",
            "pmid": "19826052",
            "pub_year": 2009,
            "title": "Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination",
            "volume": "69"
        },
        "bib3": {
            "authors": [
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Antsiferova"
                },
                {
                    "first": "Aleksandra",
                    "initial": "A.",
                    "last": "Piwko-Czuchra"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Cangkrama"
                },
                {
                    "first": "Mateusz",
                    "initial": "M.",
                    "last": "Wietecha"
                },
                {
                    "first": "Dilara",
                    "initial": "D.",
                    "last": "Sahin"
                },
                {
                    "first": "Katharina",
                    "initial": "K.",
                    "last": "Birkner"
                },
                {
                    "first": "Valerie C.",
                    "initial": "V.C.",
                    "last": "Amann"
                },
                {
                    "first": "Mitchell",
                    "initial": "M.",
                    "last": "Levesque"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Hohl"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Dummer"
                },
                {
                    "first": "Sabine",
                    "initial": "S.",
                    "last": "Werner"
                }
            ],
            "doi": "10.15252/emmm.201606493",
            "firstpage": "27",
            "issn": "17574676",
            "lastpage": "45",
            "pmid": "27932444",
            "pub_year": 2017,
            "title": "Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages",
            "volume": "9"
        },
        "bib30": {
            "authors": [
                {
                    "first": "Wanglong",
                    "initial": "W.",
                    "last": "Qiu"
                },
                {
                    "first": "Sophia M.",
                    "initial": "S.M.",
                    "last": "Tang"
                },
                {
                    "first": "Sohyae",
                    "initial": "S.",
                    "last": "Lee"
                },
                {
                    "first": "Andrew T.",
                    "initial": "A.T.",
                    "last": "Turk"
                },
                {
                    "first": "Anthony N.",
                    "initial": "A.N.",
                    "last": "Sireci"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Qiu"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Rose"
                },
                {
                    "first": "Chuangao",
                    "initial": "C.",
                    "last": "Xie"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Kitajewski"
                },
                {
                    "first": "Hui Ju",
                    "initial": "H.J.",
                    "last": "Wen"
                },
                {
                    "first": "Howard C.",
                    "initial": "H.C.",
                    "last": "Crawford"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Sims"
                },
                {
                    "first": "Ralph H.",
                    "initial": "R.H.",
                    "last": "Hruban"
                },
                {
                    "first": "Helen E.",
                    "initial": "H.E.",
                    "last": "Remotti"
                },
                {
                    "first": "Gloria H.",
                    "initial": "G.H.",
                    "last": "Su"
                }
            ],
            "doi": "10.1053/j.gastro.2015.09.013",
            "firstpage": "218",
            "issn": "00165085",
            "lastpage": "228.e12",
            "pmid": "26408346",
            "pub_year": 2016,
            "title": "Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice with Activated KRAS",
            "volume": "150"
        },
        "bib31": null,
        "bib32": {
            "authors": [
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Rodeck"
                },
                {
                    "first": "Karl",
                    "initial": "K.",
                    "last": "Melber"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Kath"
                },
                {
                    "first": "Hans Dietrich",
                    "initial": "H.D.",
                    "last": "Menssen"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Varello"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Atkinson"
                },
                {
                    "first": "Meenhard",
                    "initial": "M.",
                    "last": "Herlyn"
                }
            ],
            "doi": "10.1111/1523-1747.ep12477822",
            "firstpage": "20",
            "issn": "0022202X",
            "lastpage": "26",
            "pmid": "2056188",
            "pub_year": 1991,
            "title": "Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes",
            "volume": "97"
        },
        "bib33": {
            "authors": [
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Rodeck"
                },
                {
                    "first": "Takafumi",
                    "initial": "T.",
                    "last": "Nishiyama"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Mauviel"
                }
            ],
            "firstpage": "547",
            "issn": "00085472",
            "lastpage": "550",
            "pmid": "9973198",
            "pub_year": 1999,
            "title": "Independent regulation of growth and SMAD-mediated transcription by transforming growth factor \u03b2 in human melanoma cells",
            "volume": "59"
        },
        "bib34": {
            "authors": [
                {
                    "first": "Tobias",
                    "initial": "T.",
                    "last": "Schatton"
                },
                {
                    "first": "Markus H.",
                    "initial": "M.H.",
                    "last": "Frank"
                }
            ],
            "doi": "10.1111/j.1749-6632.2009.04568.x",
            "firstpage": "154",
            "issn": "00778923",
            "lastpage": "169",
            "pmid": "19796244",
            "pub_year": 2009,
            "title": "Antitumor immunity and cancer stem cells",
            "volume": "1176"
        },
        "bib35": {
            "authors": [
                {
                    "first": "Silvano",
                    "initial": "S.",
                    "last": "Sozzani"
                },
                {
                    "first": "Tiziana",
                    "initial": "T.",
                    "last": "Musso"
                }
            ],
            "doi": "10.1182/blood-2011-03-342691",
            "firstpage": "5013",
            "issn": "00064971",
            "lastpage": "5015",
            "pub_year": 2011,
            "title": "The yin and yang of Activin A",
            "volume": "117"
        },
        "bib36": {
            "authors": [
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Stove"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Vanrobaeys"
                },
                {
                    "first": "Bart",
                    "initial": "B.",
                    "last": "Devreese"
                },
                {
                    "first": "Jozef",
                    "initial": "J.",
                    "last": "Van Beeumen"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Mareel"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Bracke"
                }
            ],
            "doi": "10.1038/sj.onc.1207699",
            "firstpage": "5330",
            "issn": "09509232",
            "lastpage": "5339",
            "pmid": "15064726",
            "pub_year": 2004,
            "title": "Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition",
            "volume": "23"
        },
        "bib37": {
            "authors": [
                {
                    "first": "Athanasios",
                    "initial": "A.",
                    "last": "Theologides"
                }
            ],
            "doi": "10.1002/1097-0142(197905)43:5+<2004::AID-CNCR2820430708>3.0.CO;2-#",
            "firstpage": "2004",
            "issn": "0008543X",
            "lastpage": "2012",
            "pmid": "376104",
            "pub_year": 1979,
            "title": "Cancer cachexia",
            "volume": "43"
        },
        "bib38": {
            "authors": [
                {
                    "first": "Yosuke",
                    "initial": "Y.",
                    "last": "Togashi"
                },
                {
                    "first": "Akihiro",
                    "initial": "A.",
                    "last": "Kogita"
                },
                {
                    "first": "Hiroki",
                    "initial": "H.",
                    "last": "Sakamoto"
                },
                {
                    "first": "Hidetoshi",
                    "initial": "H.",
                    "last": "Hayashi"
                },
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Terashima"
                },
                {
                    "first": "Marco A.",
                    "initial": "M.A.",
                    "last": "de Velasco"
                },
                {
                    "first": "Kazuko",
                    "initial": "K.",
                    "last": "Sakai"
                },
                {
                    "first": "Yoshihiko",
                    "initial": "Y.",
                    "last": "Fujita"
                },
                {
                    "first": "Shuta",
                    "initial": "S.",
                    "last": "Tomida"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Kitano"
                },
                {
                    "first": "Kiyotaka",
                    "initial": "K.",
                    "last": "Okuno"
                },
                {
                    "first": "Masatoshi",
                    "initial": "M.",
                    "last": "Kudo"
                },
                {
                    "first": "Kazuto",
                    "initial": "K.",
                    "last": "Nishio"
                }
            ],
            "doi": "10.1016/j.canlet.2014.10.037",
            "firstpage": "819",
            "issn": "03043835",
            "lastpage": "827",
            "pmid": "25449777",
            "pub_year": 2015,
            "title": "Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer",
            "volume": "356"
        },
        "bib39": {
            "authors": [
                {
                    "first": "Yosuke",
                    "initial": "Y.",
                    "last": "Togashi"
                },
                {
                    "first": "Hiroki",
                    "initial": "H.",
                    "last": "Sakamoto"
                },
                {
                    "first": "Hidetoshi",
                    "initial": "H.",
                    "last": "Hayashi"
                },
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Terashima"
                },
                {
                    "first": "Marco A.",
                    "initial": "M.A.",
                    "last": "de Velasco"
                },
                {
                    "first": "Yoshihiko",
                    "initial": "Y.",
                    "last": "Fujita"
                },
                {
                    "first": "Yasuo",
                    "initial": "Y.",
                    "last": "Kodera"
                },
                {
                    "first": "Kazuko",
                    "initial": "K.",
                    "last": "Sakai"
                },
                {
                    "first": "Shuta",
                    "initial": "S.",
                    "last": "Tomida"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Kitano"
                },
                {
                    "first": "Akihiko",
                    "initial": "A.",
                    "last": "Ito"
                },
                {
                    "first": "Masatoshi",
                    "initial": "M.",
                    "last": "Kudo"
                },
                {
                    "first": "Kazuto",
                    "initial": "K.",
                    "last": "Nishio"
                }
            ],
            "doi": "10.1186/1476-4598-13-126",
            "issn": "14764598",
            "pmid": "24886203",
            "pub_year": 2014,
            "title": "Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer",
            "volume": "13"
        },
        "bib4": {
            "authors": [
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Bellomo"
                },
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Caja"
                },
                {
                    "first": "Aristidis",
                    "initial": "A.",
                    "last": "Moustakas"
                }
            ],
            "doi": "10.1038/bjc.2016.255",
            "firstpage": "761",
            "issn": "00070920",
            "lastpage": "769",
            "pmid": "27537386",
            "pub_year": 2016,
            "title": "Transforming growth factor \u03b2 as regulator of cancer stemness and metastasis",
            "volume": "115"
        },
        "bib40": {
            "authors": [
                {
                    "first": "Jolanta M.",
                    "initial": "J.M.",
                    "last": "Topczewska"
                },
                {
                    "first": "Lynne Marie",
                    "initial": "L.M.",
                    "last": "Postovit"
                },
                {
                    "first": "Naira V.",
                    "initial": "N.V.",
                    "last": "Margaryan"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Sam"
                },
                {
                    "first": "Angela R.",
                    "initial": "A.R.",
                    "last": "Hess"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Wheaton"
                },
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Nickoloff"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Topczewski"
                },
                {
                    "first": "Mary J.C.",
                    "initial": "M.J.C.",
                    "last": "Hendrix"
                }
            ],
            "doi": "10.1038/nm1448",
            "firstpage": "925",
            "issn": "10788956",
            "lastpage": "932",
            "pmid": "16892036",
            "pub_year": 2006,
            "title": "Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness",
            "volume": "12"
        },
        "bib41": {
            "authors": [
                {
                    "first": "Mary Jo",
                    "initial": "M.J.",
                    "last": "Turk"
                },
                {
                    "first": "Jos\u00e9 A.",
                    "initial": "J.A.",
                    "last": "Guevara-Pati\u00f1o"
                },
                {
                    "first": "Gabrielle A.",
                    "initial": "G.A.",
                    "last": "Rizzuto"
                },
                {
                    "first": "Manuel E.",
                    "initial": "M.E.",
                    "last": "Engelhorn"
                },
                {
                    "first": "Alan N.",
                    "initial": "A.N.",
                    "last": "Houghton"
                }
            ],
            "doi": "10.1084/jem.20041130",
            "firstpage": "771",
            "issn": "00221007",
            "lastpage": "782",
            "pmid": "15381730",
            "pub_year": 2004,
            "title": "Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells",
            "volume": "200"
        },
        "bib42": {
            "authors": [
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Rodeck"
                },
                {
                    "first": "Isaac",
                    "initial": "I.",
                    "last": "Nuamah"
                },
                {
                    "first": "Allan C.",
                    "initial": "A.C.",
                    "last": "Halpern"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Elder"
                }
            ],
            "firstpage": "1887",
            "issn": "00029440",
            "lastpage": "1894",
            "pmid": "8669474",
            "pub_year": 1996,
            "title": "Melanoma-associated expression of transforming growth factor-\u03b2 isoforms",
            "volume": "148"
        },
        "bib43": {
            "authors": [
                {
                    "first": "Kelly L.",
                    "initial": "K.L.",
                    "last": "Walton"
                },
                {
                    "first": "Yogeshwar",
                    "initial": "Y.",
                    "last": "Makanji"
                },
                {
                    "first": "Craig A.",
                    "initial": "C.A.",
                    "last": "Harrison"
                }
            ],
            "doi": "10.1016/j.mce.2011.06.030",
            "firstpage": "2",
            "issn": "03037207",
            "lastpage": "12",
            "pmid": "21763751",
            "pub_year": 2012,
            "title": "New insights into the mechanisms of activin action and inhibition",
            "volume": "359"
        },
        "bib44": {
            "authors": [
                {
                    "first": "Daniel S.",
                    "initial": "D.S.",
                    "last": "Widmer"
                },
                {
                    "first": "Phil F.",
                    "initial": "P.F.",
                    "last": "Cheng"
                },
                {
                    "first": "Ossia M.",
                    "initial": "O.M.",
                    "last": "Eichhoff"
                },
                {
                    "first": "Benedetta C.",
                    "initial": "B.C.",
                    "last": "Belloni"
                },
                {
                    "first": "Marie C.",
                    "initial": "M.C.",
                    "last": "Zipser"
                },
                {
                    "first": "Natalie C.",
                    "initial": "N.C.",
                    "last": "Schlegel"
                },
                {
                    "first": "Delphine",
                    "initial": "D.",
                    "last": "Javelaud"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Mauviel"
                },
                {
                    "first": "Reinhard",
                    "initial": "R.",
                    "last": "Dummer"
                },
                {
                    "first": "Keith S.",
                    "initial": "K.S.",
                    "last": "Hoek"
                }
            ],
            "doi": "10.1111/j.1755-148X.2012.00986.x",
            "firstpage": "343",
            "issn": "17551471",
            "lastpage": "353",
            "pmid": "22336146",
            "pub_year": 2012,
            "title": "Systematic classification of melanoma cells by phenotype-specific gene expression mapping",
            "volume": "25"
        },
        "bib45": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Wu"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Qi"
                },
                {
                    "first": "L. M.",
                    "initial": "L.M.",
                    "last": "Niu"
                },
                {
                    "first": "D. X.",
                    "initial": "D.X.",
                    "last": "Xie"
                },
                {
                    "first": "X. L.",
                    "initial": "X.L.",
                    "last": "Cui"
                },
                {
                    "first": "Z. H.",
                    "initial": "Z.H.",
                    "last": "Liu"
                }
            ],
            "firstpage": "4371",
            "issn": "11283602",
            "lastpage": "4378",
            "pmid": "26636525",
            "pub_year": 2015,
            "title": "Activin A as a novel biomarker for colorectal adenocarcinoma in humans",
            "volume": "19"
        },
        "bib46": {
            "authors": [
                {
                    "first": "Guang",
                    "initial": "G.",
                    "last": "Yang"
                },
                {
                    "first": "Yitang",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Emi K.",
                    "initial": "E.K.",
                    "last": "Nishimura"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Xin"
                },
                {
                    "first": "Anyu",
                    "initial": "A.",
                    "last": "Zhou"
                },
                {
                    "first": "Yinshi",
                    "initial": "Y.",
                    "last": "Guo"
                },
                {
                    "first": "Liang",
                    "initial": "L.",
                    "last": "Dong"
                },
                {
                    "first": "Mitchell F.",
                    "initial": "M.F.",
                    "last": "Denning"
                },
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Nickoloff"
                },
                {
                    "first": "Rutao",
                    "initial": "R.",
                    "last": "Cui"
                }
            ],
            "doi": "10.1016/j.molcel.2008.11.002",
            "firstpage": "554",
            "issn": "10972765",
            "lastpage": "563",
            "pmid": "19026785",
            "pub_year": 2008,
            "title": "Inhibition of PAX3 by TGF-\u03b2 Modulates Melanocyte Viability",
            "volume": "32"
        },
        "bib47": {
            "authors": [
                {
                    "first": "Miao",
                    "initial": "M.",
                    "last": "Yin"
                },
                {
                    "first": "Johanna",
                    "initial": "J.",
                    "last": "Soikkeli"
                },
                {
                    "first": "Tiina",
                    "initial": "T.",
                    "last": "Jahkola"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Virolainen"
                },
                {
                    "first": "Olli",
                    "initial": "O.",
                    "last": "Saksela"
                },
                {
                    "first": "Erkki",
                    "initial": "E.",
                    "last": "H\u00f6ltt\u00e4"
                }
            ],
            "doi": "10.1016/j.ajpath.2012.08.027",
            "firstpage": "2202",
            "issn": "00029440",
            "lastpage": "2216",
            "pmid": "23063511",
            "pub_year": 2012,
            "title": "TGF-\u03b2 Signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells",
            "volume": "181"
        },
        "bib48": {
            "authors": [
                {
                    "first": "Xiaolan",
                    "initial": "X.",
                    "last": "Zhou"
                },
                {
                    "first": "Jin Lin",
                    "initial": "J.L.",
                    "last": "Wang"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Lu"
                },
                {
                    "first": "Yanping",
                    "initial": "Y.",
                    "last": "Song"
                },
                {
                    "first": "Keith S.",
                    "initial": "K.S.",
                    "last": "Kwak"
                },
                {
                    "first": "Qingsheng",
                    "initial": "Q.",
                    "last": "Jiao"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Rosenfeld"
                },
                {
                    "first": "Qing",
                    "initial": "Q.",
                    "last": "Chen"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Boone"
                },
                {
                    "first": "W. Scott",
                    "initial": "W.S.",
                    "last": "Simonet"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Lacey"
                },
                {
                    "first": "Alfred L.",
                    "initial": "A.L.",
                    "last": "Goldberg"
                },
                {
                    "first": "H. Q.",
                    "initial": "H.Q.",
                    "last": "Han"
                }
            ],
            "doi": "10.1016/j.cell.2010.07.011",
            "firstpage": "531",
            "issn": "00928674",
            "lastpage": "543",
            "pmid": "20723755",
            "pub_year": 2010,
            "title": "Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival",
            "volume": "142"
        },
        "bib5": {
            "authors": [
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Breit"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Ashman"
                },
                {
                    "first": "J\u00f6rg",
                    "initial": "J.",
                    "last": "Wilting"
                },
                {
                    "first": "Jochen",
                    "initial": "J.",
                    "last": "R\u00f6ssler"
                },
                {
                    "first": "Elissavet",
                    "initial": "E.",
                    "last": "Hatzi"
                },
                {
                    "first": "Theodore",
                    "initial": "T.",
                    "last": "Fotsis"
                },
                {
                    "first": "Lothar",
                    "initial": "L.",
                    "last": "Schweigerer"
                }
            ],
            "firstpage": "4596",
            "issn": "00085472",
            "lastpage": "4601",
            "pmid": "10969812",
            "pub_year": 2000,
            "title": "The N-myc oncogene in human neuroblastoma cells: Down-regulation of an angiogenesis inhibitor identified as activin A",
            "volume": "60"
        },
        "bib6": {
            "authors": [
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Caramel"
                },
                {
                    "first": "Eftychios",
                    "initial": "E.",
                    "last": "Papadogeorgakis"
                },
                {
                    "first": "Louise",
                    "initial": "L.",
                    "last": "Hill"
                },
                {
                    "first": "Gareth J.",
                    "initial": "G.J.",
                    "last": "Browne"
                },
                {
                    "first": "Geoffrey",
                    "initial": "G.",
                    "last": "Richard"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Wierinckx"
                },
                {
                    "first": "Gerald",
                    "initial": "G.",
                    "last": "Saldanha"
                },
                {
                    "first": "Joy",
                    "initial": "J.",
                    "last": "sborne"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Hutchinson"
                },
                {
                    "first": "Gina",
                    "initial": "G.",
                    "last": "Tse"
                },
                {
                    "first": "Jo\u00ebl",
                    "initial": "J.",
                    "last": "Lachuer"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Puisieux"
                },
                {
                    "first": "J. Howard",
                    "initial": "J.H.",
                    "last": "Pringle"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Ansieau"
                },
                {
                    "first": "Eugene",
                    "initial": "E.",
                    "last": "Tulchinsky"
                }
            ],
            "doi": "10.1016/j.ccr.2013.08.018",
            "firstpage": "466",
            "issn": "15356108",
            "lastpage": "480",
            "pmid": "24075834",
            "pub_year": 2013,
            "title": "A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma",
            "volume": "24"
        },
        "bib7": {
            "authors": [
                {
                    "first": "Wan Jun",
                    "initial": "W.J.",
                    "last": "Chen"
                },
                {
                    "first": "Wenwen",
                    "initial": "W.",
                    "last": "Jin"
                },
                {
                    "first": "Neil",
                    "initial": "N.",
                    "last": "Hardegen"
                },
                {
                    "first": "Ke Jian",
                    "initial": "K.J.",
                    "last": "Lei"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Marinos"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "McGrady"
                },
                {
                    "first": "Sharon M.",
                    "initial": "S.M.",
                    "last": "Wahl"
                }
            ],
            "doi": "10.1084/jem.20030152",
            "firstpage": "1875",
            "issn": "00221007",
            "lastpage": "1886",
            "pmid": "14676299",
            "pub_year": 2003,
            "title": "Conversion of Peripheral CD4+CD25- Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-\u03b2 Induction of Transcription Factor Foxp3",
            "volume": "198"
        },
        "bib8": {
            "authors": [
                {
                    "first": "Alev",
                    "initial": "A.",
                    "last": "Deli"
                },
                {
                    "first": "Emanuel",
                    "initial": "E.",
                    "last": "Kreidl"
                },
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Santifaller"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Trotter"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "Seir"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Berger"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "Schulte-Hermann"
                },
                {
                    "first": "Chantal",
                    "initial": "C.",
                    "last": "Rodgarkia-Dara"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Grusch"
                }
            ],
            "doi": "10.3748/wjg.14.1699",
            "firstpage": "1699",
            "issn": "10079327",
            "lastpage": "1709",
            "pmid": "18350601",
            "pub_year": 2008,
            "title": "Activins and activin antagonists in hepatocellular carcinoma",
            "volume": "14"
        },
        "bib9": {
            "authors": [
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "Fearon"
                },
                {
                    "first": "Jann",
                    "initial": "J.",
                    "last": "Arends"
                },
                {
                    "first": "Vickie",
                    "initial": "V.",
                    "last": "Baracos"
                }
            ],
            "doi": "10.1038/nrclinonc.2012.209",
            "firstpage": "90",
            "issn": "17594774",
            "lastpage": "99",
            "pmid": "23207794",
            "pub_year": 2013,
            "title": "Understanding the mechanisms and treatment options in cancer cachexia",
            "volume": "10"
        }
    },
    "body_text": [
        {
            "endOffset": 27377,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Lentivirally transduced AIIB-Fc inhibited endogenous Activin activity in the conditioned medium of C8161 cells in vitro and was readily detected by immunoblotting in C8161 tumor xenografts (Figure 1d and e).",
            "startOffset": 27170,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 47441,
            "parents": [],
            "secId": "sec5",
            "sentence": "Daniel B. Constam: http://orcid.org/0000-0002-6256-3891",
            "startOffset": 47386,
            "title": "ORCID"
        },
        {
            "endOffset": 32738,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "One possible mechanism how paracrine Activin-A signaling accelerates tumor growth is by inhibiting tumor immune surveillance.",
            "startOffset": 32613,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 37389,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.1",
            "sentence": "Our main finding is that paracrine Activin-A signaling was tumorigenic specifically in immunocompetent hosts, despite a proapoptotic function of autocrine Activin/Nodal receptor signaling within melanoma cells.",
            "startOffset": 37179,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 25638,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Because we observed no NODAL expression in human melanoma, we decided to reassess how C8161 cells stimulate Nodal/Activin receptors in zebrafish.",
            "startOffset": 25493,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 33724,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "In good agreement, the same lentiviral INH\u03b2A transgene also failed to stimulate tumor growth or experimental lung metastases in xenografts of human melanoma cell lines in immunodeficient FoxN1nu/nu mice (Supplementary Figure S5d\u2013g).",
            "startOffset": 33492,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 28700,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib10": {
                    "endOffset": 28575,
                    "startOffset": 28563
                }
            },
            "secId": "sec2.3",
            "sentence": "To evaluate potential tumorigenic or prometastatic effects of Activin-A in immunocompetent hosts, we transduced INH\u03b2A in the moderately metastatic syngeneic B16F1 mouse melanoma model (Fidler, 1973) using lentiviruses for green fluorescent protein alone (CTRL) or green fluorescent protein together with Activin-A (INH\u03b2A).",
            "startOffset": 28378,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 21372,
            "parents": [],
            "refoffsets": {
                "bib30": {
                    "endOffset": 21370,
                    "startOffset": 21332
                },
                "bib39": {
                    "endOffset": 21370,
                    "startOffset": 21332
                }
            },
            "secId": "sec1",
            "sentence": "Paradoxically, its receptor ALK4 (ACVR1B) primarily mediates tumor suppressive functions and is frequently deleted in clinical samples (Qiu et al., 2016; Togashi et al., 2014).",
            "startOffset": 21196,
            "title": "Introduction"
        },
        {
            "endOffset": 35146,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "However, FACS sorting of dissociated B16F1 melanoma at the experimental endpoint revealed no changes in total myeloid populations, and M2-like macrophages marked by CD206 staining were decreased in INH\u03b2A compared with CTRL tumors (Supplementary Figure S8c).",
            "startOffset": 34889,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 44561,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Pigmented metastases visible at the surface of each lung lobe were counted 3 weeks after injection.",
            "startOffset": 44462,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 38926,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib2": {
                    "endOffset": 38924,
                    "startOffset": 38900
                }
            },
            "secId": "sec3.1",
            "sentence": "Induction of metastatic disease in chemically induced squamous cell carcinoma by a keratinocyte-specific INH\u03b2A transgene facilitates infiltration by immunosuppressive Tregs while reducing the number of resident \u03b3\u03b4-TCR-positive dendritic epidermal T-lymphocytes, consistent with a potential role in promoting immune evasion (Antsiferova et al., 2011).",
            "startOffset": 38576,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 29138,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Transfection of the SMAD3 luciferase reporter CAGA-Luc showed elevated autocrine Activin-A signaling in INH\u03b2A- compared with CTRL-transduced B16F1 cells, and this increase was blocked on treatment with FST (Figure 2b, left panel).",
            "startOffset": 28908,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 20205,
            "parents": [],
            "refoffsets": {
                "bib12": {
                    "endOffset": 20203,
                    "startOffset": 20140
                },
                "bib41": {
                    "endOffset": 20203,
                    "startOffset": 20140
                },
                "bib7": {
                    "endOffset": 20203,
                    "startOffset": 20140
                }
            },
            "secId": "sec1",
            "sentence": "In metastatic B16F10 mouse melanoma, TGF\u03b2 also reduces natural killer cell-mediated tumor rejection while promoting the differentiation of immunosuppressive Foxp3+ regulatory T cells in tumor beds and draining lymph nodes (Chen et al., 2003; Gorelik and Flavell, 2001; Turk et al., 2004).",
            "startOffset": 19917,
            "title": "Introduction"
        },
        {
            "endOffset": 44229,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "A total of 1 \u00d7 106 B16F1 cells were injected intradermally into the right flank of 8- to 12-week-old female wild-type (Harlan) or Rag1\u2212/\u2212 C57BL/6 (EPFL animal core facility) syngeneic hosts, or of Hsd-athymic nu/nu mice (Harlan).",
            "startOffset": 44000,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 23274,
            "parents": [],
            "secId": "sec1",
            "sentence": "Our comparison of melanoma grafts in tumor hosts of different genetic backgrounds reveals a protumorigenic and prometastatic function specifically for paracrine Activin-A signaling acting on adaptive immunity, and that this function can be uncoupled from immune-independent anorexic and proangiogenic effects and from autocrine effects on melanoma cell differentiation.",
            "startOffset": 22905,
            "title": "Introduction"
        },
        {
            "endOffset": 45517,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.2",
            "sentence": "Quantitative polymerase chain reaction assays were performed using SYBR green chemistry according to manufacturers\u2019 instructions (Applied Biosystems, Waltham, MA), or commercial Taqman probe for INH\u03b2A (Eurogentec, Li\u00e8ge, Belgium).",
            "startOffset": 45287,
            "title": "Gene expression analysis"
        },
        {
            "endOffset": 43412,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib3": {
                    "endOffset": 43410,
                    "startOffset": 43386
                }
            },
            "secId": "sec3.4",
            "sentence": "Possibly, class I inflammatory macrophages that stimulate vascularization in Activin-induced skin squamous cell carcinoma mediate proangiogenic activity (Antsiferova et al., 2017).",
            "startOffset": 43232,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 40734,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib8": {
                    "endOffset": 40732,
                    "startOffset": 40715
                }
            },
            "secId": "sec3.2",
            "sentence": "In the hepatocyte lineage, autocrine antiproliferative Activin-A signaling is frequently attenuated by secreted antagonists in hepatocarcinoma (reviewed in Deli et al., 2008).",
            "startOffset": 40559,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 34673,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "Conversely, pimonidazole staining of hypoxic areas in the same sections was 4-fold reduced, indicating that Activin-induced blood vessels were functional (Supplementary Figure S8a and b online).",
            "startOffset": 34479,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 41724,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.3",
            "sentence": "If cachexia similarly curbs the growth of B16F1 melanoma growth, tumor growth should slow down concurring with the onset of Activin-induced cachexia at least in immunodeficient hosts.",
            "startOffset": 41541,
            "title": "Interplay of tumor growth and cachexia"
        },
        {
            "endOffset": 32056,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "Tumors induced no overt loss of body weight (Figure 3e), and they grew significantly less in doxycycline-fed animals than in vehicle-treated controls (Figure 3f), indicating that sustained autocrine Activin receptor signaling does not stimulate but rather suppresses tumor growth in vivo.",
            "startOffset": 31768,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 40558,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "Because melanoma cell survival was impaired by caALK4 but not by secreted Activin-A, autocrine signaling activity of the ligand is likely attenuated in transformed cells compared with normal melanocytes.",
            "startOffset": 40355,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 40941,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib15": {
                    "endOffset": 40939,
                    "startOffset": 40901
                },
                "bib36": {
                    "endOffset": 40939,
                    "startOffset": 40901
                }
            },
            "secId": "sec3.2",
            "sentence": "Also in human melanoma, dynamic changes in the levels of FST expression during progression of melanoma in situ to metastatic growth may modulate Activin-A responses (Heinz et al., 2015; Stove et al., 2004).",
            "startOffset": 40735,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 30125,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Compared with vector control, INH\u03b2A also increased the number of experimental lung metastases formed by tumor cells that were injected into the tail vein (Figure 2i).",
            "startOffset": 29959,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 44365,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Tumor volumes were calculated using the formula length \u00d7 width \u00d7 depth.",
            "startOffset": 44294,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 43964,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.4",
            "sentence": "Overall, our findings suggest that paracrine Activin-A should be considered as a target for personalized therapies not only to reduce cachexia and melanoma vascularization, but also to enhance the efficacy of immunotherapies.",
            "startOffset": 43739,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 19404,
            "parents": [],
            "refoffsets": {
                "bib1": {
                    "endOffset": 19248,
                    "startOffset": 19203
                },
                "bib32": {
                    "endOffset": 19248,
                    "startOffset": 19203
                },
                "bib33": {
                    "endOffset": 19402,
                    "startOffset": 19383
                }
            },
            "secId": "sec1",
            "sentence": "In normal melanocytes, TGF\u03b2 induces cell cycle arrest and apoptosis (Alanko and Saksela, 2000; Rodeck et al., 1991), but this response is attenuated in cells from benign nevi despite sustained activation of downstream SMAD2,3 transcription factors (Rodeck et al., 1999).",
            "startOffset": 19134,
            "title": "Introduction"
        },
        {
            "endOffset": 37909,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.1",
            "sentence": "By contrast, in syngeneic Rag1\u2212/\u2212 hosts that lack T- and B-lymphocytes, or in athymic FoxN1nu/nu mice devoid of only T cells, neither blockade of endogenous Activin/Nodal receptor ligands in the human C8161 melanoma cell line nor overexpression of Activin-A revealed a tumorigenic function.",
            "startOffset": 37619,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 20477,
            "parents": [],
            "refoffsets": {
                "bib11": {
                    "endOffset": 20475,
                    "startOffset": 20432
                },
                "bib47": {
                    "endOffset": 20475,
                    "startOffset": 20432
                }
            },
            "secId": "sec1",
            "sentence": "However, the functionally relevant active TGF\u03b2 in this model is provided by immature myeloid dendritic cells in draining lymph nodes, likely because B16F10 and other melanoma cells themselves secrete TGF\u03b2 only in latent form (Ghiringhelli et al., 2005; Yin et al., 2012).",
            "startOffset": 20206,
            "title": "Introduction"
        },
        {
            "endOffset": 32334,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "Immunostaining at the endpoint of the experiment revealed increased apoptosis marked by cleaved Caspase-3 (Figure 3g, Supplementary Figure S7e), whereas Ki67-stained proliferating cells appeared to decrease, albeit not significantly (Figure 3h and i, Supplementary Figure S7f).",
            "startOffset": 32057,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 28907,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Western blot analysis of B16F1-conditioned medium and cell lysates confirmed Activin-A secretion that increased the accumulation of pSmad2 compared with CTRL cells that do not secrete Activin-A (Figure 2a).",
            "startOffset": 28701,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 43231,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.4",
            "sentence": "T-cell-derived cytokines are unlikely involved because Activin-A stimulated the vascularization of B16F1 tumors even in Rag1\u2212/\u2212 syngeneic hosts.",
            "startOffset": 43087,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 41817,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.3",
            "sentence": "Such a trend in Rag1\u2212/\u2212 hosts was not statistically significant and not seen in nu/nu hosts.",
            "startOffset": 41725,
            "title": "Interplay of tumor growth and cachexia"
        },
        {
            "endOffset": 36321,
            "parents": [],
            "secId": "sec3",
            "sentence": "Tumorigenic paracrine effects on adaptive immunity trumped proapoptotic autocrine signals within cancer cells to overall facilitate primary and metastatic growth.",
            "startOffset": 36159,
            "title": "Discussion"
        },
        {
            "endOffset": 19594,
            "parents": [],
            "refoffsets": {
                "bib29": {
                    "endOffset": 19592,
                    "startOffset": 19554
                },
                "bib46": {
                    "endOffset": 19592,
                    "startOffset": 19554
                }
            },
            "secId": "sec1",
            "sentence": "SMAD-binding sites in the PAX3 gene mediating repression of pigment synthesis likely contribute to melanoma cell plasticity and phenotype switching (Pinner et al., 2009; Yang et al., 2008).",
            "startOffset": 19405,
            "title": "Introduction"
        },
        {
            "endOffset": 44461,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Experimental lung metastases were obtained by injecting 3 \u00d7 105 B16F1 cells into the tail vein.",
            "startOffset": 44366,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 18827,
            "parents": [],
            "secId": "sec1",
            "sentence": "Thus, elucidating mechanisms of tumor immune evasion and their coupling to cancer cell plasticity is critical to develop effective immunotherapies.",
            "startOffset": 18680,
            "title": "Introduction"
        },
        {
            "endOffset": 18980,
            "parents": [],
            "secId": "sec1",
            "sentence": "Known local cues in the tumor microenvironment that regulate melanoma cell plasticity and antitumor immunity include transforming growth factor \u03b2 (TGF\u03b2).",
            "startOffset": 18827,
            "title": "Introduction"
        },
        {
            "endOffset": 19916,
            "parents": [],
            "refoffsets": {
                "bib19": {
                    "endOffset": 19914,
                    "startOffset": 19887
                },
                "bib20": {
                    "endOffset": 19914,
                    "startOffset": 19887
                },
                "bib42": {
                    "endOffset": 19716,
                    "startOffset": 19694
                }
            },
            "secId": "sec1",
            "sentence": "TGF\u03b2 immunostaining was found to correlate with the invasive vertical growth phase and metastasis (Van Belle et al., 1996), and blockade of downstream SMAD2,3 transcription factors by overexpression of antagonistic SMAD7 in 1205Lu melanoma cells inhibited tumorigenicity and bone metastasis (Javelaud et al., 2005, 2007).",
            "startOffset": 19595,
            "title": "Introduction"
        },
        {
            "endOffset": 27734,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "However, despite potent systemic inhibition of cachexia, soluble AIIB-Fc receptor neither diminished intradermal tumor growth nor experimental lung metastases after tail vein injection (Figure 1g and h).",
            "startOffset": 27531,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 39991,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "This confirms that oncogenic Activin-A activity in immunocompetent syngeneic hosts was mediated by paracrine signaling.",
            "startOffset": 39872,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 33852,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "These results strongly suggest that Activin-A accelerates B16F1 melanoma growth by blunting T-cell-mediated antitumor immunity.",
            "startOffset": 33725,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 35705,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "Interestingly, angiogenesis was similarly increased in Rag1\u2212/\u2212 hosts where tumor growth remained unchanged on INH\u03b2A overexpression, suggesting that increased vascularization alone cannot account for the tumorigenic effects of Activin-A (Figure 5b).",
            "startOffset": 35457,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 38190,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.1",
            "sentence": "Technical artifacts arising from clonal variation or specific cell lines are unlikely because we used nonclonal pools of lentivirally transduced cells, and reproducible results were obtained with multiple independent batches of cells and with additional human melanoma cell lines.",
            "startOffset": 37910,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 26401,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Moreover, both wild-type and MZoep embryos ectopically upregulated gsc as well as ntl around grafted C8161 melanoma cells (Supplementary Figure S4b).",
            "startOffset": 26252,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 30585,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "To validate whether the tumorigenic function of Activin-A involves cell nonautonomous paracrine signaling, we transduced B16F1 cells with lentivirus expressing a constitutively active ligand-independent truncated form of ALK4 (caALK4).",
            "startOffset": 30350,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 25835,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib13": {
                    "endOffset": 25833,
                    "startOffset": 25812
                }
            },
            "secId": "sec2.2",
            "sentence": "To address this, we grafted C8161 cells into wild-type or mutant zebrafish embryos lacking maternal and zygotic expression of the Nodal coreceptor one-eyed pinhead (MZoep) (Gritsman et al., 1999).",
            "startOffset": 25639,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 21195,
            "parents": [],
            "refoffsets": {
                "bib26": {
                    "endOffset": 21193,
                    "startOffset": 21151
                },
                "bib38": {
                    "endOffset": 21193,
                    "startOffset": 21151
                }
            },
            "secId": "sec1",
            "sentence": "For example in mouse models of pancreatic cancer, Activin-A promotes tumor progression by inhibiting cell differentiation (Lonardo et al., 2011; Togashi et al., 2015).",
            "startOffset": 21028,
            "title": "Introduction"
        },
        {
            "endOffset": 40288,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "Although we cannot rule out that forced ALK4 signaling may induce nonphysiological levels of Smad2/3 phosphorylation, cell proliferation and survival are also inhibited in normal melanocytes treated with Activin-A.",
            "startOffset": 40074,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 32945,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "In keeping with this idea, immunostaining of tumor sections with anti-CD8 antibody revealed that Activin-A expression significantly inhibited tumor infiltration by cytotoxic T-lymphocytes (Figure 4a and b).",
            "startOffset": 32739,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 43739,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.4",
            "sentence": "Although the total number of infiltrating macrophages was unchanged by Activin-A in B16F1 melanoma under the conditions examined, and because increased angiogenesis was not sufficient to promote tumor growth, we did not further investigate whether Activin-A directly polarized a proangiogenic macrophage subtype in this model.",
            "startOffset": 43413,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 39095,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib3": {
                    "endOffset": 39093,
                    "startOffset": 39069
                }
            },
            "secId": "sec3.1",
            "sentence": "Depletion of CD4-positive T cells, including Tregs, did not suppress the tumorigenicity of transgenic Activin-A in this skin carcinoma model (Antsiferova et al., 2017).",
            "startOffset": 38927,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 47176,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.4",
            "sentence": "All statistical analyses were performed using GraphPad Prism v6 software.",
            "startOffset": 47103,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 22028,
            "parents": [],
            "refoffsets": {
                "bib15": {
                    "endOffset": 22026,
                    "startOffset": 22008
                }
            },
            "secId": "sec1",
            "sentence": "Interestingly, however, gain of transgenic Activin-A expression in the A375 human melanoma xenograft model did not alter tumor growth or metastasis, even though it reduced tumor lymphangiogenesis, a risk factor of poor prognosis (Heinz et al., 2015).",
            "startOffset": 21778,
            "title": "Introduction"
        },
        {
            "endOffset": 37101,
            "parents": [],
            "secId": "sec3",
            "sentence": "Based on these findings, future strategies to boost the efficacy of immunotherapies should consider targeting Activin-A.",
            "startOffset": 36981,
            "title": "Discussion"
        },
        {
            "endOffset": 47337,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.4",
            "sentence": "Data were analyzed using Mann-Whitney (for nonparametric data), t-tests, and 1-way or 2-way analysis of variance with Bonferroni correction for parametric data.",
            "startOffset": 47177,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27169,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "To assess the function of endogenous ligands in melanoma xenografts, we transduced human C8161 cells with lentivirus expressing an Fc fusion of Activin type IIB receptor extracellular domain (AIIB-Fc) or Fc alone.",
            "startOffset": 26956,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 36158,
            "parents": [],
            "secId": "sec3",
            "sentence": "Here, we propose that the net outcome of a gain in paracrine Activin-A signaling in mouse and human melanoma grafts is determined by whether or not the tumor host has functional adaptive immunity.",
            "startOffset": 35962,
            "title": "Discussion"
        },
        {
            "endOffset": 29958,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Mice injected with INH\u03b2A-transduced cells grew significantly larger tumors, combined with loss of body weight and cardiac muscle wasting (Figure 2f\u2013h).",
            "startOffset": 29807,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 24366,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib44": {
                    "endOffset": 24364,
                    "startOffset": 24345
                }
            },
            "secId": "sec2.1",
            "sentence": "Elevated INH\u03b2A expression significantly clustered with a standard gene expression signature of invasive rather than proliferative melanoma cell lines as determined by Heuristic Online Phenotype Prediction analysis (Figure 1b) (Widmer et al., 2012).",
            "startOffset": 24118,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 46767,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "Dissociated cells were stained with live and dead blue dye (Life Technologies, Carlsbad, CA), and washed and labeled with antibodies against CD45-APC-Vio770 (Miltenyi, 130-105-463), CD31-BV605 (BD Biosciences, Franklin Lakes, NJ, 740356), and CD140a-PE (eBioscience, Waltham, MA, 12-1401-81) to exclude leukocytes, endothelial cells, and fibroblasts, respectively.",
            "startOffset": 46403,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 38576,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib22": {
                    "endOffset": 38574,
                    "startOffset": 38533
                },
                "bib26": {
                    "endOffset": 38574,
                    "startOffset": 38533
                }
            },
            "secId": "sec3.1",
            "sentence": "Notable exceptions are pancreatic and esophageal cancer and R30C mammary carcinoma cells where gain of autocrine Activin signaling directly stimulates tumor cell stemness or survival (Krneta et al., 2006; Lonardo et al., 2011).",
            "startOffset": 38349,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 29601,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Furthermore, gain of Activin-A expression in B16F1 cells stimulated their migration in a scratch wound assay and markedly reduced their melanin content without altering their cell proliferation or viability (Figure 2c\u2013e), consistent with a potential autocrine function in promoting a phenotypic switch.",
            "startOffset": 29299,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 37618,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.1",
            "sentence": "Thus, a lentiviral INH\u03b2A transgene encoding secreted Activin-A in syngeneic B16F1 mouse melanoma grafts increased intradermal tumor growth and the frequency of experimental lung metastases specifically in wild-type C57BL/6 mice.",
            "startOffset": 37390,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 22511,
            "parents": [],
            "secId": "sec1",
            "sentence": "Here, we asked whether a potential tumorigenic role for Activin signaling in melanoma may be curtailed in xenografts by the absence of a functional immune system.",
            "startOffset": 22349,
            "title": "Introduction"
        },
        {
            "endOffset": 42342,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.4",
            "sentence": "However, a similar increase of blood vessels in Rag1\u2212/\u2212 hosts was not sufficient to facilitate tumor growth.",
            "startOffset": 42234,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 42789,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib22": {
                    "endOffset": 42787,
                    "startOffset": 42768
                }
            },
            "secId": "sec3.4",
            "sentence": "Although we could not stain enough tumors in Rag1\u2212/\u2212 mice with pimonidazole to formally exclude a stimulatory effect of adaptive immunity on vessel functionality and hypoxia, it is interesting to note that tumor growth was also uncoupled from angiogenesis in immunodeficient SCID mice bearing mammary carcinoma xenografts, where gain of Activin-A signaling diminished tumor angiogenesis without affecting vascular perfusion (Krneta et al., 2006).",
            "startOffset": 42343,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 22904,
            "parents": [],
            "secId": "sec1",
            "sentence": "To address this, we monitored the expression of INH\u03b2A in public datasets and in a panel of melanoma tumors and cell lines, and we performed loss- and gain-of-function studies, respectively, in human xenografts and in the moderately metastatic syngeneic B16F1 mouse melanoma model using dominant negative or ligand-independent mutant Activin/Nodal receptors or Activin-A lentiviral transgenes.",
            "startOffset": 22512,
            "title": "Introduction"
        },
        {
            "endOffset": 46171,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "Cells were then washed and stained with DAPI and analyzed using a CyAn ADP analyzer (Beckman Coulter, Brea, CA).",
            "startOffset": 46059,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 46996,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "After washing, cells were fixed and permeabilized using FoxP3 fix and perm buffer set (eBiosciences) and stained with eFluor 450-conjugated Ki67 antibodies (eBiosciences, 48-5698-80) using permeabilization buffer (eBiosciences).",
            "startOffset": 46768,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 23420,
            "parents": [],
            "secId": "sec1",
            "sentence": "Our findings suggest that gain of Activin-A expression in human melanoma should be considered as a potential target for improved immunotherapies.",
            "startOffset": 23275,
            "title": "Introduction"
        },
        {
            "endOffset": 31767,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "To investigate the impact on tumor growth, B16F1 cells transduced with caALK4 were grafted intradermally into syngeneic C57BL/6 hosts, followed by treatment with doxycycline or empty vehicle until the endpoint of the experiment.",
            "startOffset": 31539,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 21027,
            "parents": [],
            "refoffsets": {
                "bib27": {
                    "endOffset": 21025,
                    "startOffset": 21003
                }
            },
            "secId": "sec1",
            "sentence": "Activin-A can mediate protective or tumorigenic effects (reviewed in Loomans and Andl, 2014).",
            "startOffset": 20934,
            "title": "Introduction"
        },
        {
            "endOffset": 25274,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib15": {
                    "endOffset": 25272,
                    "startOffset": 25235
                },
                "bib48": {
                    "endOffset": 25272,
                    "startOffset": 25235
                }
            },
            "secId": "sec2.2",
            "sentence": "Previous analysis of Activin-A functions in tumor xenograft models uncovered potent anorexic activity but no important roles in tumor progression (Heinz et al., 2015; Zhou et al., 2010).",
            "startOffset": 25088,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 46402,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "For Ki67 immunostaining, tumors were dissociated into single cells in 0.02 mg/ml DNase I and 1 mg/ml collagenase mix (Sigma-Aldrich, St. Louis, MO) using a GentleMACS tissue octo dissociator (Miltenyi, Bergisch Gladbach, Germany).",
            "startOffset": 46172,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 42233,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.4",
            "sentence": "We found that paracrine Activin-A signaling in the syngeneic B16F1 melanoma model also stimulated tumor vascularization.",
            "startOffset": 42113,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 41540,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib38": {
                    "endOffset": 41538,
                    "startOffset": 41518
                }
            },
            "secId": "sec3.3",
            "sentence": "In pancreatic MIA PaCa-2 xenografts, a comparison of tumor growth with the time course of Activin-induced cachexia suggests that associated metabolic changes or general weakening curtails a growth-promoting effect of autocrine Activin signaling (Togashi et al., 2015).",
            "startOffset": 41272,
            "title": "Interplay of tumor growth and cachexia"
        },
        {
            "endOffset": 18307,
            "parents": [],
            "secId": "sec1",
            "sentence": "Patients with resistant melanoma have a poor prognosis due to high probability of metastasis, correlating with progression from superficial spreading to invasive vertical growth.",
            "startOffset": 18129,
            "title": "Introduction"
        },
        {
            "endOffset": 30807,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "Induction of caALK4 by doxycycline led to increased Smad2,3 phosphorylation and expression of the SMAD3-dependent luciferase reporter CAGA-Luc (Figure 3a\u2013c) and reduced pigment secretion (Supplementary Figure S6a online).",
            "startOffset": 30586,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 36756,
            "parents": [],
            "secId": "sec3",
            "sentence": "Thus, a potential boost in nutrient supply by recycled tissue breakdown products was either insufficient to fuel tumorigenesis or neutralized by growth-inhibitory autocrine Activin receptor signaling within tumor cells.",
            "startOffset": 36537,
            "title": "Discussion"
        },
        {
            "endOffset": 39316,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.1",
            "sentence": "However, it will be interesting to compare in future studies the potential of Tregs or tumor-infiltrating cytotoxic T-lymphocytes or other T-cell subsets to mediate effects of Activin-A on antitumor immunity in melanoma.",
            "startOffset": 39096,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 31538,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "A similar reduction in the number of viable cells was induced by ligand-independent caALK4 in human C8161 melanoma cells.",
            "startOffset": 31417,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 34120,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib24": {
                    "endOffset": 34118,
                    "startOffset": 34100
                }
            },
            "secId": "sec2.6",
            "sentence": "Depending on the context, Activin-A signaling may also promote or inhibit angiogenesis that can be rate-limiting for tumor oxygenation and nutrient supply (Lewis et al., 2016).",
            "startOffset": 33944,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 36980,
            "parents": [],
            "secId": "sec3",
            "sentence": "To our knowledge, these results furnish direct evidence that adaptive immunity is required for a tumorigenic Activin function, and that autocrine and paracrine signaling mediates opposite effects on melanoma growth in vivo.",
            "startOffset": 36757,
            "title": "Discussion"
        },
        {
            "endOffset": 23658,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib31": {
                    "endOffset": 23656,
                    "startOffset": 23638
                }
            },
            "secId": "sec2.1",
            "sentence": "To assess potential roles of INH\u03b2A in melanoma, we queried a gene expression profiling dataset of 42 primary cutaneous tumors (Riker et al., 2008).",
            "startOffset": 23511,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 26748,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "To test whether melanoma may grow faster when forced to express Nodal, C8161 cells transduced with Nodal lentivirus (Supplementary Figure S2d) were grafted subcutaneously into FoxN1nu/nu mice.",
            "startOffset": 26556,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 39544,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib16": {
                    "endOffset": 39542,
                    "startOffset": 39508
                },
                "bib45": {
                    "endOffset": 39542,
                    "startOffset": 39508
                }
            },
            "secId": "sec3.1",
            "sentence": "A role in suppressing antitumor immunity may explain why INH\u03b2A expression is more frequently upregulated in human melanoma and other solid human tumors than expected for a neutral bystander (Hoda et al., 2016; Wu et al., 2015).",
            "startOffset": 39317,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 30957,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "However, caALK4 expression decreased below detection within four subsequent cell passages despite the continuous presence of doxycycline (Figure 3a).",
            "startOffset": 30808,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 35456,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "Also in human melanoma with the highest levels of Activin-A, markers of lymphocytic or myeloid infiltrates appeared to be reduced rather than increased (Supplementary Figure S9 online), although recruitment of such infiltrates or their functions may vary depending on Activin-A signaling strength or duration.",
            "startOffset": 35147,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 18128,
            "parents": [],
            "refoffsets": {
                "bib23": {
                    "endOffset": 18126,
                    "startOffset": 18110
                }
            },
            "secId": "sec1",
            "sentence": "In melanoma research, targeted inhibitors and immune checkpoint therapies are available, but their efficacies remain limited by acquired and intrinsic drug resistance mechanisms (Lau et al., 2016).",
            "startOffset": 17931,
            "title": "Introduction"
        },
        {
            "endOffset": 31416,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "5-ethynyl-2\u2019-deoxyuridine incorporation, AnnexinV and propidium iodide flow cytometry, and cleaved Caspase3 immunofluorescence staining after up to 3 days of caALK4 induction in vitro revealed no overt cell cycle inhibition or apoptosis (Supplementary Figure S7a\u2013d online and data not shown), even though the number of cells detected by Alamar blue assays after 3 days of caALK4 induction in vitro was reduced (Figure 3d), indicating impaired cell viability.",
            "startOffset": 30958,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 20582,
            "parents": [],
            "refoffsets": {
                "bib15": {
                    "endOffset": 20580,
                    "startOffset": 20543
                },
                "bib18": {
                    "endOffset": 20580,
                    "startOffset": 20543
                }
            },
            "secId": "sec1",
            "sentence": "Melanoma cell lines and tumors also frequently express Activin-A (Heinz et al., 2015; Hoek et al., 2006).",
            "startOffset": 20477,
            "title": "Introduction"
        },
        {
            "endOffset": 24843,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.1",
            "sentence": "Although survival did not correlate with either INH\u03b2A or NODAL, low expression of the Activin antagonist Follistatin in the TCGA dataset was associated with worse outcome (Supplementary Figure S3 online).",
            "startOffset": 24639,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 26251,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "We found that both human Nodal and the zebrafish homolog Squint were active in wild-type but not in MZoep, whereas human Activin-A induced gsc independently of Oep (Supplementary Figure S4a online).",
            "startOffset": 26053,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 45583,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.2",
            "sentence": "PCR primer sequences are listed in Supplementary Table S1 online.",
            "startOffset": 45518,
            "title": "Gene expression analysis"
        },
        {
            "endOffset": 24638,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.1",
            "sentence": "Furthermore, although RT-PCR analysis confirmed INH\u03b2A expression in more than half of a panel of 20 human melanoma cell lines, the related ligands encoded by INH\u03b2B or NODAL were rarely transcribed or undetectable, respectively (Figure 1c, Supplementary Figure S2 online).",
            "startOffset": 24367,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 47503,
            "parents": [],
            "secId": "sec6",
            "sentence": "The authors state no conflict of interest.",
            "startOffset": 47461,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 21584,
            "parents": [],
            "refoffsets": {
                "bib36": {
                    "endOffset": 21582,
                    "startOffset": 21564
                }
            },
            "secId": "sec1",
            "sentence": "Cytostatic and proapoptotic signaling by Activin-A has also been reported in human melanoma cell lines, although this activity is counteracted by the secreted antagonist Follistatin (FST-1) (Stove et al., 2004).",
            "startOffset": 21373,
            "title": "Introduction"
        },
        {
            "endOffset": 18679,
            "parents": [],
            "refoffsets": {
                "bib17": {
                    "endOffset": 18677,
                    "startOffset": 18591
                },
                "bib34": {
                    "endOffset": 18677,
                    "startOffset": 18591
                },
                "bib44": {
                    "endOffset": 18677,
                    "startOffset": 18591
                },
                "bib6": {
                    "endOffset": 18677,
                    "startOffset": 18591
                }
            },
            "secId": "sec1",
            "sentence": "Tumor-initiating potential and metastasis also correlate with low immunogenic profiles of subpopulations of cells and phenotypic plasticity marked by pseudoepithelial-to-mesenchymal transitions and the ability to reversibly switch between proliferative and invasive gene signatures (Caramel et al., 2013; Hoek et al., 2008; Schatton and Frank, 2009; Widmer et al., 2012).",
            "startOffset": 18308,
            "title": "Introduction"
        },
        {
            "endOffset": 23896,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.1",
            "sentence": "We found that INH\u03b2A expression was significantly elevated both in primary cutaneous cancers and in metastatic melanoma, whereas the antagonist FST tended to decrease in melanoma in situ (n = 2, not significant) compared with normal skin.",
            "startOffset": 23659,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 33240,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "To directly test whether paracrine Activin-A signaling promotes tumor progression by inhibiting antitumor immunity, B16F1 cells were inoculated subcutaneously or intravenously into FoxN1nu/nu that lack functional T cells, or into Rag1\u2212/\u2212 mice devoid of V-D-J recombination in antigen receptors.",
            "startOffset": 32946,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 22349,
            "parents": [],
            "refoffsets": {
                "bib25": {
                    "endOffset": 22347,
                    "startOffset": 22313
                },
                "bib48": {
                    "endOffset": 22347,
                    "startOffset": 22313
                }
            },
            "secId": "sec1",
            "sentence": "Also in xenograft models of other cancers, overexpression of a dominant negative mutant receptor revealed no adverse functions for Activin-A or related ligands, with the exception of tumor-induced systemic weight loss (cachexia) through remote Smad2,3 activation in skeletal muscles (Li et al., 2007; Zhou et al., 2010).",
            "startOffset": 22029,
            "title": "Introduction"
        },
        {
            "endOffset": 24117,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.1",
            "sentence": "In contrast to INH\u03b2A, other Activin receptor ligands encoded by NODAL or GDF3 were neither upregulated in this dataset nor in a TCGA collection of 474 skin cutaneous melanomas (Figure 1a, Supplementary Figure S1 online).",
            "startOffset": 23897,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 41271,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib9": {
                    "endOffset": 41269,
                    "startOffset": 41250
                }
            },
            "secId": "sec3.3",
            "sentence": "Commonly associated with advanced cancer in human patients, cachexia reduces life quality and drug responses while increasing morbidity and mortality (Fearon et al., 2013).",
            "startOffset": 41099,
            "title": "Interplay of tumor growth and cachexia"
        },
        {
            "endOffset": 47381,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.4",
            "sentence": "A P-value <0.05 was considered significant.",
            "startOffset": 47338,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19133,
            "parents": [],
            "refoffsets": {
                "bib28": {
                    "endOffset": 19131,
                    "startOffset": 19090
                },
                "bib4": {
                    "endOffset": 19131,
                    "startOffset": 19090
                }
            },
            "secId": "sec1",
            "sentence": "In many tumors including melanoma, TGF\u03b2 facilitates or inhibits tumor progression, depending on the context (Bellomo et al., 2016; Perrot et al., 2013).",
            "startOffset": 18981,
            "title": "Introduction"
        },
        {
            "endOffset": 36536,
            "parents": [],
            "secId": "sec3",
            "sentence": "Ectopic Activin-A signaling also stimulated tumor vascularization and, concurring with previous reports, systemic cachexia, and these effects were preserved in Rag1\u2212/\u2212 mice albeit without accelerating tumor growth.",
            "startOffset": 36322,
            "title": "Discussion"
        },
        {
            "endOffset": 45151,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.2",
            "sentence": "Total RNA from melanoma cell lines and tumors was isolated using Trizol reagent (Thermo Fisher Scientific, Waltham, MA) and guanidinium/CsCl gradient, respectively, or by using the RNeasyMini kit (Qiagen, Venlo, Netherlands).",
            "startOffset": 44926,
            "title": "Gene expression analysis"
        },
        {
            "endOffset": 30254,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Taken together, these results show that Activin-A signaling can promote melanoma growth and metastasis in immunocompetent hosts.",
            "startOffset": 30126,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 21777,
            "parents": [],
            "refoffsets": {
                "bib15": {
                    "endOffset": 21775,
                    "startOffset": 21757
                }
            },
            "secId": "sec1",
            "sentence": "Immunohistochemical analysis detected Activin-A staining in superficially spreading melanoma, whereas benign nevi and metastatic lesions showed elevated expression of FST (Heinz et al., 2015).",
            "startOffset": 21585,
            "title": "Introduction"
        },
        {
            "endOffset": 41061,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "However, whether FST influences the balance between autocrine and paracrine Activin signaling remains to be determined.",
            "startOffset": 40942,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 38348,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib48": {
                    "endOffset": 38346,
                    "startOffset": 38329
                }
            },
            "secId": "sec3.1",
            "sentence": "In keeping with our observations, also other tumor types in immunocompromised mice revealed minimal or no oncogenic effects of Activin-A (Zhou et al., 2010).",
            "startOffset": 38191,
            "title": "Activin-A only stimulates melanoma growth in mice that have functional T cells"
        },
        {
            "endOffset": 20933,
            "parents": [],
            "refoffsets": {
                "bib14": {
                    "endOffset": 20931,
                    "startOffset": 20866
                },
                "bib35": {
                    "endOffset": 20931,
                    "startOffset": 20866
                },
                "bib43": {
                    "endOffset": 20931,
                    "startOffset": 20866
                }
            },
            "secId": "sec1",
            "sentence": "Activin-A stimulates the same SMAD transcription factors as TGF\u03b2, even though it derives from distinct precursor dimers encoded by the Inhibin \u03b2A (INH\u03b2A) gene and binds distinct complexes of the Activin/Nodal type I and II receptors Acvr1b/ALK4 or Acvr1c/ALK7 and Acvr2 (reviewed in Hedger et al., 2011; Sozzani and Musso, 2011; Walton et al., 2011).",
            "startOffset": 20583,
            "title": "Introduction"
        },
        {
            "endOffset": 47083,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "Samples were acquired using an LSRII cytometer (Becton Dickinson, Franklin Lakes, NJ).",
            "startOffset": 46997,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 42042,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib37": {
                    "endOffset": 42040,
                    "startOffset": 42023
                }
            },
            "secId": "sec3.3",
            "sentence": "The observed tumor growth curves also do not support a model that cachexia is rate-limiting for the supply of essential amino acids and other metabolites to cancer cells in a process of \u201cautocannibalism\u201d (Theologides, 1979).",
            "startOffset": 41818,
            "title": "Interplay of tumor growth and cachexia"
        },
        {
            "endOffset": 26556,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "These results strongly argue for secreted Activin-A and against Nodal as the mediator of Smad2,3 signaling secreted by C8161 melanoma grafts in zebrafish.",
            "startOffset": 26402,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 25492,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib40": {
                    "endOffset": 25490,
                    "startOffset": 25467
                }
            },
            "secId": "sec2.2",
            "sentence": "Instead, increased aggressiveness in human melanoma has been attributed to a secreted Nodal-like activity that was initially detected by injecting C8161 melanoma cells into zebrafish embryos (Topczewska et al., 2006).",
            "startOffset": 25275,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 39871,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "We found that in contrast to secreted Activin-A, autocrine signaling by a doxycycline-inducible ligand-independent mutant ALK4 transgene inhibited B16F1 tumor growth rather than stimulating it.",
            "startOffset": 39678,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 40073,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "Induction of caALK4 also inhibited the expansion of cultured B16F1 cells ex vivo.",
            "startOffset": 39992,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 24943,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.1",
            "sentence": "These results are consistent with a potential role for Activin-A signaling in melanoma progression.",
            "startOffset": 24844,
            "title": "Human melanoma and other skin cancers frequently express Activin-A rather than NODAL"
        },
        {
            "endOffset": 32522,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.4",
            "sentence": "We conclude that whereas paracrine functions of Activin-A promote cachexia and tumor growth, sustained autocrine receptor signaling in vivo reduces B16F1 cell survival and tumorigenicity.",
            "startOffset": 32335,
            "title": "Sustained cell autonomous ALK4 signaling inhibits B16F1 tumorigenesis rather than stimulating it"
        },
        {
            "endOffset": 29806,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "To determine if the oncogenic effects of Activin-A gain of function may promote tumor growth in vivo, B16F1 grafts were intradermally inoculated on the right flank of 8- to 10-week-old female C57BL/6 mice.",
            "startOffset": 29601,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 34306,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "To assess whether increased tumor growth correlates with increased tumor vascularization, we labeled blood vessels in thick cryosections of syngeneic B16F1 grafts using CD31 antibodies.",
            "startOffset": 34121,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 34478,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.6",
            "sentence": "Quantification in z-stack reconstructions of entire sections of 15 CTRL and 14 INH\u03b2A tumors showed that Activin-A significantly increased the vascular density (Figure 5a).",
            "startOffset": 34307,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 27530,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "As expected, expression of AIIB-Fc in C8161 xenografts significantly protected FoxN1nu/nu hosts against loss of body weight and muscle mass (Figure 1f).",
            "startOffset": 27378,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 40354,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "secId": "sec3.2",
            "sentence": "By contrast, Activin-A-treated B16F1 cells proliferated normally.",
            "startOffset": 40289,
            "title": "Inhibition of melanoma growth by autocrine signaling may curtail oncogenic effects of secreted Activin-A on the tumor microenvironment"
        },
        {
            "endOffset": 34888,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib21": {
                    "endOffset": 34792,
                    "startOffset": 34773
                }
            },
            "secId": "sec2.6",
            "sentence": "Because Activin-A has been shown to inhibit endothelial cell growth and tubule formation in vitro (Kaneda et al., 2011), we asked whether its proangiogenic effect in B16F1 melanoma could be mediated by macrophages.",
            "startOffset": 34674,
            "title": "Angiogenesis is enhanced by Activin-A but is not sufficient to promote B16F1 melanoma growth"
        },
        {
            "endOffset": 29298,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Conditioned medium from INH\u03b2A-transduced B16F1 cells also stimulated the expression of transfected CAGA-Luc in HEK293T reporter cells (Figure 2b, right panel).",
            "startOffset": 29139,
            "title": "Activin-A gain of function promotes phenotype switching of mouse melanoma cells and tumor progression"
        },
        {
            "endOffset": 43086,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib21": {
                    "endOffset": 43025,
                    "startOffset": 42965
                },
                "bib22": {
                    "endOffset": 43025,
                    "startOffset": 42965
                },
                "bib5": {
                    "endOffset": 43025,
                    "startOffset": 42965
                }
            },
            "secId": "sec3.4",
            "sentence": "Interestingly, however, Activin signaling within endothelial cells in this breast cancer model and other tumors was cytostatic and reduced sprouting and blood vessel density (Breit et al., 2000; Kaneda et al., 2011; Krneta et al., 2006), indicating that proangiogenic activity is likely indirect.",
            "startOffset": 42790,
            "title": "Activin-induced tumor angiogenesis and its uncoupling from tumor growth"
        },
        {
            "endOffset": 44293,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Animal body weights and tumor sizes were measured every 2 days.",
            "startOffset": 44230,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 28277,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "These results suggest that C8161 xenografts grow and metastasize independently of Activin signaling and of associated systemic cachexia, possibly because of the lack of functional adaptive immunity.",
            "startOffset": 28079,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 44787,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "All procedures were according to Swiss legislation and approved by the cantonal veterinary administration.",
            "startOffset": 44681,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 28078,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Additionally, secondary tumor outgrowths after resection of the primary C8161 graft and spontaneous lung or lymph node metastases were not significantly inhibited (Supplementary Figure S5a\u2013c online), nor did AIIB-Fc transduction inhibit experimental lung metastases of Me343 cells that also express INH\u03b2A (Figure 1i, Supplementary Figure S2g).",
            "startOffset": 27735,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 35961,
            "parents": [],
            "secId": "sec3",
            "sentence": "Previous studies reported both tumor-suppressive and oncogenic effects of Activin-A, but a role in antitumor immunity and the relative contributions of autocrine versus paracrine signaling in an in vivo model of melanoma remained to be evaluated.",
            "startOffset": 35715,
            "title": "Discussion"
        },
        {
            "endOffset": 44902,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Generation of cell lines and in vitro assays are further documented in Supplementary Materials and Methods online.",
            "startOffset": 44788,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 44680,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.1",
            "sentence": "Where indicated, animals were fed with chow containing 0.625 g/kg doxycycline (Provimi Kliba AG, Gossau, Switzerland).",
            "startOffset": 44562,
            "title": "Melanoma grafts"
        },
        {
            "endOffset": 26052,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "To validate that human NODAL signaling requires Oep in zebrafish, we injected 50 pg of mRNA encoding human Nodal at the one-cell stage and monitored induction of the Smad2,3 target gene gsc during early gastrulation.",
            "startOffset": 25836,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        },
        {
            "endOffset": 33491,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.5",
            "sentence": "In sharp contrast to immune-competent wild-type hosts, loss of either FoxN1 or Rag1 enabled CTRL tumors to grow as fast as those with sustained INH\u03b2A expression, even though Activin-A provoked cachexia irrespective of the host genotype (Figure 4a\u2013f).",
            "startOffset": 33241,
            "title": "Activin-A-dependent B16F1 melanoma growth is mediated by impaired tumor immune surveillance"
        },
        {
            "endOffset": 46058,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.3",
            "sentence": "After treatment with 250 \u03bcg/ml doxycycline for 24, 48 or 72 hours in 6-well plates, cells were incubated with 10 \u03bcM 5-ethynyl-2\u2019-deoxyuridine for 30 minutes and then trypsinized, washed with phosphate buffered saline, and fixed for 20 minutes with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 in phosphate buffered saline, and stained for 30 minutes with Alexa-647-coupled azide in the presence of copper sulfate and sodium ascorbate.",
            "startOffset": 45611,
            "title": "Cell cycle and Ki67 analysis"
        },
        {
            "endOffset": 45286,
            "parents": [
                {
                    "id": "sec4",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "sec4.2",
            "sentence": "One microgram of total RNA was used for cDNA synthesis using the Superscript III Reverse Transcription Kit (Invitrogen, Carlsbad, CA).",
            "startOffset": 45152,
            "title": "Gene expression analysis"
        },
        {
            "endOffset": 26955,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Results"
                }
            ],
            "secId": "sec2.2",
            "sentence": "C8161 xenograft tumor growth was not increased by Nodal compared with cells transduced with empty vector, indicating that it was not limited by the lack of Nodal expression (Supplementary Figure S4e and f).",
            "startOffset": 26749,
            "title": "Inhibition of endogenous ActRIIB ligands in human C8161 melanoma cells inhibits cachexia but not tumor progression in immunocompromised nude mice"
        }
    ],
    "docId": "S0022202X17328208",
    "metadata": {
        "asjc": [
            "1303",
            "1307",
            "1312",
            "2708"
        ],
        "authors": [
            {
                "email": null,
                "first": "Prudence",
                "initial": "P.",
                "last": "Donovan"
            },
            {
                "email": null,
                "first": "Olivier A.",
                "initial": "O.A.",
                "last": "Dubey"
            },
            {
                "email": null,
                "first": "Susanna",
                "initial": "S.",
                "last": "Kallioinen"
            },
            {
                "email": null,
                "first": "Katherine W.",
                "initial": "K.W.",
                "last": "Rogers"
            },
            {
                "email": null,
                "first": "Katja",
                "initial": "K.",
                "last": "Muehlethaler"
            },
            {
                "email": null,
                "first": "Patrick",
                "initial": "P.",
                "last": "M\u00fcller"
            },
            {
                "email": null,
                "first": "Donata",
                "initial": "D.",
                "last": "Rimoldi"
            },
            {
                "email": "Daniel.Constam@epfl.ch",
                "first": "Daniel B.",
                "initial": "D.B.",
                "last": "Constam"
            }
        ],
        "doi": "10.1016/j.jid.2017.07.845",
        "firstpage": "2578",
        "issn": "0022202X",
        "lastpage": "2587",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "MEDI"
        ],
        "title": "Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion"
    }
}